• Product NameIpratropium Bromide
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityIpratropium Bromide is an antagonist of M3 type muscarinic acetylcholine receptors, used for the treatment of chronic obstructive pulmonary disease (COPD).
• Target NameAChR antagonist
• CAS No. 22254-24-6
• Calculated MW 412.37
• Formulation C20H30BrNO3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:[Br-].CC(C)[N+]1(C)C2CCC1C[C@H](C2)OC(=O)C(CO)C1=CC=CC=C1 |r,c:22,24,t:20|
  Pathways:Neuroscience
  Receptor:M3 mAChR
  Boling pt:
  Melting pt:
  Solubility:DMSO:83 mg/mL (201.27 mM)Ethanol:83 mg/mL (201.27 mM)Water:83 mg/mL (201.27 mM)
  Appearance:
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Zhang W, et al. Eur J Pharmacol,?010, 647(1-3), 178-187.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting